# Haemonetics acquires Vivasure Medical for up to €185 million

Haemonetics Corporation acquired Vivasure Medical Limited, a Galway, Ireland-based developer of percutaneous vessel closure technology, for an upfront cash payment of €100 million plus up to €85 million in contingent consideration.

- Type: Acquisition
- Announced: 2026-01-09
- Where: Galway, Ireland
- Value: $105.0M (100.0M EUR)
- Status: completed
- Products: PerQseal Elite vessel closure system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Haemonetics](https://endata.com/companies/47664.md) (acquirer)
- [Vivasure Medical](https://endata.com/companies/89558.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/haemonetics-acquires-vivasure-medical-limited-302657255.html), 2026-01-09: "Haemonetics Corporation...today announced the acquisition of Vivasure Medical Limited."
- [businessplus.ie](https://businessplus.ie/ma/vivasure-haemonetics/), 2026-01-09: "Vivasure Medical, the Galway-based medical device company, has been acquired by the NYSE-listed Haemonetics Corporation in a deal worth up to €185m if certain conditions are met."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.